Prophylactic antibiotic

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC, Benaroya Research Institute

Conditions

Antibiotic StewardshipOnabotulinumtoxin AOveractive BladderOveractive Urinary BladderUTI

Phase 1

A Study of the Pharmacokinetics and Pharmacodynamics of Vibegron (MK-4618) in Women With Overactive Bladder (MK-4618-004)

TerminatedNCT01500382

Merck Sharp & Dohme LLCOveractive Bladder, Overactive Urinary Bladder

Start: 2012-02-27End: 2013-01-02Updated: 2018-12-24

Unknown Phase

Antibiotic Usage Prior to OnabotulinumtoxinA Injection

RecruitingNCT04754737

Benaroya Research InstituteAntibiotic Stewardship, Onabotulinumtoxin A, Overactive Bladder +1

Start: 2021-03-23End: 2026-12-31Target: 200Updated: 2024-05-24